Stran & Company Financials
This page shows Stran & Company (SWAGW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue growth has been real, but SG&A-heavy scaling keeps Stran near break-even and leaves cash generation inconsistent.
From FY2023 to FY2025, gross profit rose by$9.4M while operating cash flow stayed negative, ending at-$4.7M . Even with narrower net losses, growth was not self-funding because overhead and working-capital needs absorbed the extra gross profit.
Gross margin has hovered around
The balance sheet still looks equity-funded rather than debt-driven, with reported leverage at 0.6x and a current ratio of 2.3x in FY2025. But the cash cushion has thinned from
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Stran & Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Stran & Company has an operating margin of -1.7%, meaning the company retains $-2 of operating profit per $100 of revenue. This below-average margin results in a low score of 16/100, suggesting thin profitability after operating expenses. This is up from -5.9% the prior year.
Stran & Company's revenue surged 40.6% year-over-year to $116.2M, reflecting rapid business expansion. This strong growth earns a score of 73/100.
Stran & Company carries a low D/E ratio of 0.62, meaning only $0.62 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 89/100, indicating a strong balance sheet with room for future borrowing.
Stran & Company's current ratio of 2.34 indicates adequate short-term liquidity, earning a score of 43/100. The company can meet its near-term obligations, though with limited headroom.
While Stran & Company generated -$4.7M in operating cash flow, capex of $823K consumed most of it, leaving -$5.5M in free cash flow. This results in a low score of 19/100, reflecting heavy capital investment rather than weak cash generation.
Stran & Company generates a -2.5% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -13.1% the prior year.
Stran & Company passes 4 of 9 financial strength tests. 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Stran & Company generates $6.26 in operating cash flow (-$4.7M OCF vs -$747K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Stran & Company generated $116.2M in revenue in fiscal year 2025. This represents an increase of 40.6% from the prior year.
Stran & Company's EBITDA was -$850K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 79.1% from the prior year.
Stran & Company reported -$747K in net income in fiscal year 2025. This represents an increase of 82.0% from the prior year.
Stran & Company earned $-0.04 per diluted share (EPS) in fiscal year 2025. This represents an increase of 81.8% from the prior year.
Cash & Balance Sheet
Stran & Company generated -$5.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 354.6% from the prior year.
Stran & Company held $6.8M in cash against $0 in long-term debt as of fiscal year 2025.
Stran & Company had 19M shares outstanding in fiscal year 2025. This represents a decrease of 0.5% from the prior year.
Margins & Returns
Stran & Company's gross margin was 29.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.8 percentage points from the prior year.
Stran & Company's operating margin was -1.7% in fiscal year 2025, reflecting core business profitability. This is up 4.2 percentage points from the prior year.
Stran & Company's net profit margin was -0.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 4.4 percentage points from the prior year.
Stran & Company's ROE was -2.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 10.6 percentage points from the prior year.
Capital Allocation
Stran & Company spent $554K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
Stran & Company invested $823K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 36.9% from the prior year.
SWAGW Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $31.2M+8.0% | $28.9M+11.4% | $26.0M-20.2% | $32.6M+13.5% | $28.7M+6.3% | $27.0M+34.0% | $20.1M+20.7% | $16.7M |
| Cost of Revenue | $21.6M+7.3% | $20.1M+6.5% | $18.9M-16.7% | $22.7M+12.3% | $20.2M+11.0% | $18.2M+28.3% | $14.2M+26.4% | $11.2M |
| Gross Profit | $9.6M+9.5% | $8.8M+24.5% | $7.1M-28.3% | $9.9M+16.4% | $8.5M-3.4% | $8.8M+47.5% | $6.0M+8.9% | $5.5M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $9.0M+1.8% | $8.8M-0.1% | $8.9M-6.5% | $9.5M+5.1% | $9.0M-7.2% | $9.7M+19.4% | $8.1M+23.7% | $6.6M |
| Operating Income | $645K+1942.9% | -$35K+98.0% | -$1.8M-551.1% | $395K+173.8% | -$535K+42.9% | -$937K+57.1% | -$2.2M-97.1% | -$1.1M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $46K-60.3% | $116K+261.1% | -$72K-163.2% | $114K+400.0% | -$38K | N/A | -$1K-133.3% | $3K |
| Net Income | $744K+206.2% | $243K+119.6% | -$1.2M-292.8% | $643K+263.6% | -$393K+32.9% | -$586K+71.2% | -$2.0M-98.8% | -$1.0M |
| EPS (Diluted) | $0.04 | N/A | $-0.07-333.3% | $0.03+250.0% | $-0.02 | N/A | $-0.11-83.3% | $-0.06 |
SWAGW Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $53.2M+7.7% | $49.3M-1.8% | $50.3M-17.9% | $61.2M+17.4% | $52.2M-5.4% | $55.1M+13.0% | $48.8M+4.8% | $46.6M |
| Current Assets | $42.9M+11.1% | $38.6M-1.8% | $39.3M-21.5% | $50.1M+18.7% | $42.2M-7.2% | $45.5M+17.7% | $38.6M-5.4% | $40.9M |
| Cash & Equivalents | $7.6M+13.3% | $6.8M+0.8% | $6.7M-48.8% | $13.1M+208.5% | $4.2M-54.7% | $9.4M-6.8% | $10.0M-15.5% | $11.9M |
| Inventory | $8.6M+12.2% | $7.6M-1.5% | $7.7M+14.9% | $6.7M-12.0% | $7.7M+42.1% | $5.4M+13.0% | $4.8M+20.0% | $4.0M |
| Accounts Receivable | $17.4M+1.1% | $17.3M+3.8% | $16.6M-24.6% | $22.1M+20.6% | $18.3M+1.1% | $18.1M+31.6% | $13.7M+14.4% | $12.0M |
| Goodwill | $2.3M0.0% | $2.3M0.0% | $2.3M0.0% | $2.3M0.0% | $2.3M0.0% | $2.3M-8.7% | $2.5M | N/A |
| Total Liabilities | $21.8M+15.4% | $18.8M-6.1% | $20.1M-31.7% | $29.4M+40.7% | $20.9M-11.1% | $23.5M+42.4% | $16.5M+34.1% | $12.3M |
| Current Liabilities | $19.6M+18.5% | $16.5M-4.7% | $17.3M-34.9% | $26.6M+38.4% | $19.2M-13.3% | $22.2M+48.8% | $14.9M+40.0% | $10.7M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $31.4M+3.0% | $30.5M+1.0% | $30.2M-5.1% | $31.8M+1.8% | $31.3M-1.2% | $31.6M-2.0% | $32.3M-5.8% | $34.3M |
| Retained Earnings | -$6.7M+9.9% | -$7.5M+3.1% | -$7.7M-19.1% | -$6.5M+9.0% | -$7.1M-5.8% | -$6.7M-9.5% | -$6.2M-49.5% | -$4.1M |
SWAGW Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2M+632.9% | $161K+103.0% | -$5.4M-183.5% | $6.4M+209.1% | -$5.9M-541.9% | $1.3M+148.6% | -$2.7M-230.0% | $2.1M |
| Capital Expenditures | $4K-96.7% | $123K-75.3% | $498K+538.5% | $78K-37.1% | $124K+33.3% | $93K-35.4% | $144K-18.2% | $176K |
| Free Cash Flow | $1.2M+2994.7% | $38K+100.6% | -$5.9M-192.4% | $6.3M+205.5% | -$6.0M-585.1% | $1.2M+143.0% | -$2.9M-249.3% | $1.9M |
| Investing Cash Flow | -$250K-345.1% | $102K+117.8% | -$572K-119.8% | $2.9M+258.0% | $809K+139.5% | -$2.0M-284.9% | $1.1M+13.1% | $980K |
| Financing Cash Flow | -$35K+83.1% | -$207K+52.2% | -$433K+11.1% | -$487K-1117.5% | -$40K-205.3% | $38K+118.4% | -$206K+70.6% | -$700K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | $0-100.0% | $408K | N/A | N/A | N/A | N/A | N/A |
SWAGW Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 30.9%+0.4pp | 30.4%+3.2pp | 27.2%-3.1pp | 30.3%+0.7pp | 29.6%-3.0pp | 32.5%+3.0pp | 29.5%-3.2pp | 32.8% |
| Operating Margin | 2.1%+2.2pp | -0.1%+6.7pp | -6.9%-8.1pp | 1.2%+3.1pp | -1.9%+1.6pp | -3.5%+7.4pp | -10.8%-4.2pp | -6.6% |
| Net Margin | 2.4%+1.5pp | 0.8%+5.6pp | -4.8%-6.7pp | 2.0%+3.3pp | -1.4%+0.8pp | -2.2%+8.0pp | -10.1%-4.0pp | -6.1% |
| Return on Equity | 2.4%+1.6pp | 0.8%+4.9pp | -4.1%-6.1pp | 2.0%+3.3pp | -1.3%+0.6pp | -1.9%+4.5pp | -6.3%-3.3pp | -3.0% |
| Return on Assets | 1.4%+0.9pp | 0.5%+3.0pp | -2.5%-3.5pp | 1.1%+1.8pp | -0.8%+0.3pp | -1.1%+3.1pp | -4.2%-2.0pp | -2.2% |
| Current Ratio | 2.20-0.1 | 2.34+0.1 | 2.27+0.4 | 1.88-0.3 | 2.20+0.1 | 2.05-0.5 | 2.59-1.2 | 3.83 |
| Debt-to-Equity | 0.69+0.1 | 0.62-0.0 | 0.66-0.3 | 0.92+0.3 | 0.67-0.1 | 0.74+0.2 | 0.51+0.2 | 0.36 |
| FCF Margin | 3.8%+3.6pp | 0.1%+22.7pp | -22.6%-42.1pp | 19.5%+40.4pp | -21.0%-25.6pp | 4.6%+18.9pp | -14.3%-25.9pp | 11.6% |
Similar Companies
Frequently Asked Questions
What is Stran & Company's annual revenue?
Stran & Company (SWAGW) reported $116.2M in total revenue for fiscal year 2025. This represents a 40.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Stran & Company's revenue growing?
Stran & Company (SWAGW) revenue grew by 40.6% year-over-year, from $82.7M to $116.2M in fiscal year 2025.
Is Stran & Company profitable?
No, Stran & Company (SWAGW) reported a net income of -$747K in fiscal year 2025, with a net profit margin of -0.6%.
What is Stran & Company's EBITDA?
Stran & Company (SWAGW) had EBITDA of -$850K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Stran & Company's gross margin?
Stran & Company (SWAGW) had a gross margin of 29.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Stran & Company's operating margin?
Stran & Company (SWAGW) had an operating margin of -1.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Stran & Company's net profit margin?
Stran & Company (SWAGW) had a net profit margin of -0.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Stran & Company's return on equity (ROE)?
Stran & Company (SWAGW) has a return on equity of -2.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Stran & Company's free cash flow?
Stran & Company (SWAGW) generated -$5.5M in free cash flow during fiscal year 2025. This represents a -354.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Stran & Company's operating cash flow?
Stran & Company (SWAGW) generated -$4.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Stran & Company's total assets?
Stran & Company (SWAGW) had $49.3M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Stran & Company's capital expenditures?
Stran & Company (SWAGW) invested $823K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Stran & Company's current ratio?
Stran & Company (SWAGW) had a current ratio of 2.34 as of fiscal year 2025, which is generally considered healthy.
What is Stran & Company's debt-to-equity ratio?
Stran & Company (SWAGW) had a debt-to-equity ratio of 0.62 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Stran & Company's return on assets (ROA)?
Stran & Company (SWAGW) had a return on assets of -1.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Stran & Company's cash runway?
Based on fiscal year 2025 data, Stran & Company (SWAGW) had $6.8M in cash against an annual operating cash burn of $4.7M. This gives an estimated cash runway of approximately 17 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Stran & Company's Piotroski F-Score?
Stran & Company (SWAGW) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Stran & Company's earnings high quality?
Stran & Company (SWAGW) has an earnings quality ratio of 6.26x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Stran & Company?
Stran & Company (SWAGW) scores 40 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.